Drug-Induced Pulmonary Disease Flashcards

1
Q

How many medications can cause lung injury?

A

350 and they all manifest in a variety of ways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common drug induced respiratory problem?

A

Drug-induced bronchospams

Usually seen in patients with pre-existing bronchial hyper-reactivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the mechanisms of bronchospams?

A
Anaphylaxis (IgE-mediated)
Penicillins
Sulfonamides
Serum
Cephalosporins
Can occur with any drug

Cyclooxygenase inhibition
Aspirin/NSAIDs

Pharmacologic effects
β -adrenergic blockers

Direct airway irritation
Smoke
N-acetylcysteine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the aspirin triad (Samter’s syndrome)?

A

Asthma
Nasal Polyps
And aspirin intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aspirin/NSAID bronchospasm- presentation

A

Bronchospasm, rhinorrhea, conjunctivitis, flushing
Urticaria, periorbital edema, abdominal pain
Can present separately or blended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aspirin/NSAID bronchospasm- sx resolution

A

Diminish within 24-48 hours

urticaria may continue 1-2 wks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aspirin/NSAID bronchospasm- diagnosis

A
No in vitro diagnostic test to confirm or establish aspirin sensitivity
Provocation challenge
Respiratory reactions
30 -150mg (average 60 mg)
Completed in hospital
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aspirin/NSAID bronchospasm- management

A

Avoid aspirin and nonselective NSAIDs
Cross sensitivity
Ibuprofen (98%)
Naproxen (100%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aspirin/NSAID bronchospasm- desensitization and leukotriene modifiers

A

Elimination of reactions by slowly increasing doses of oral aspirin

Leukotriene modifiers
Dose response curve shifted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aspirin/NSAID bronchospasm- therapy options

A
Therapy options
COX-2 selective NSAIDs (Celecoxib)
Generally can be used safely in patients with ASA induced asthma
Acetaminophen
5% of ASA sensitive patients react
< 1000 mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aspirin/NSAID bronchospasm- cross-sensitivity

A

Up to 80% of ASA-sensitive patient had AE to yellow azo dye tartrazine (FD&C Yellow No.5)
Colors food, drinks, drugs, cosmetics
FDA requires labeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The use of ________ might increase the risk of asthma and allergic disease when used early in life?

A

Acetaminophen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Beta blocker bronchospasm

A

Effects seen with oral, IV or ophthalmic administration
Rarely seen in patients without pulmonary disease
Reaction can be fatal
Primarily with non-selective β-blockers
Patients taking β -blockers without incident for long periods of time may experience fatal asthma attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Beta blocker bronchospasm- symptoms

A
Symptoms
Increased pulmonary symptoms
Decreased pulmonary function tests
Decrease in FEV1 or peak expiratory flow
Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Beta blocker bronchospasm- Mechanism

A

Direct inhibition of β2-receptors may result in bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Beta blocker bronchospasm- management

A

Inhaled bronchodilator for bronchospasm
Avoidance
If necessary, use selective β-blockers
Use lowest dose possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Will treatmeant with beta blockers in patients with COPD reduce the risk of exacerbations and improve survival?`

A

It might

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sulfite induced bronchospasm

A
Potassium metabisulfite
Preservative in food and wine
Injectable epinephrine, isoproterenol
Rare in general population
1-5% in patients with asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Sulfite induced bronchospasm- patient presentation

A

Severe wheezing, chest tightness and dyspnea after ingestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Sulfite induced bronchospasm- Diagnosis

A

History

Re-challenge- in a controlled setting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Sulfite induced bronchospasm- mechanism

A

Sulfite converted to sulfur dioxide in acidic or warm environment
Sulfur dioxide causes direct stimulation of parasympathetic receptors
IgE-mediated (anaphylactic reactions)
Reduced concentration of sulfite oxidase enzyme reported in sulfite-sensitive asthma patients
Catalyzes oxidation of sulfites to sulfates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Sulfite induced bronchospasm- management

A

Avoidance
Read labels
Pharmacologic agents
» Manufacturers of drugs for the treatment of asthma have discontinued use of sulfites
Food products
» Labeling required on packaged foods that contain sulfites at 10 ppm or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Sulfite induced bronchospasm- pretreatment

A

Cromolyn, anticholinergics, cyanocobalamin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Inhaled agents bronchospasm

A

Nonspecific bronchial irritant effect
Usually NOT caused by medication
Propellant, delivery, pH, osmolality, temperature, preservative
Albuterol, cromolyn, inhaled corticosteroids, pentamidine, N-acetyl cysteine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Is the bronchospasm from inhaled medications caused by the medication itself?
No its caused by the other chemicals that are in the drug
26
Inhaled agents- bronchospasm- Ethylenediamine tetraacetic acid (EDTA)
``` Stabilizing agent Mechanism Calcium chelation property Benzalkonium chloride Bacteriostatic agent Found in some albuterol nebulization multi-dose vials ``` Mechanism Mast cell degranulation Management Change therapy
27
Ace Inhibitors-cough- risk factors
Female Asian descent Elderly Heart failure
28
Do patients with asthma or COPD appear to be at an increased risk for development of a cough with ace inhibitor use?
No
29
Ace Inhibitors-cough- symptoms
Cough Tickle to debilitating cough with insomnia and vomiting Dry, nonproductive, hacking cough Patients have normal spirometry and chest xray
30
Ace Inhibitors-cough- mechanism
``` Not fully known Usually attributed to accumulation of bradykinin and substance P Bradykinin Stimulate cough reflex Substance P Cause bronchoconstriction ```
31
Ace Inhibitors-cough- management
Cough may resolve within a few weeks Usually stop medication Cough resolves within a few days to a month after discontinuation Usually unresponsive to cough suppressants or bronchodilators
32
Fentanyl cough
IV formulation Unclear mechanism Associated with young age and absence of smoking History of asthma/COPD not predictive
33
What is narcotic induced non-cardiogenic pulmonary edema most commonly assoiciated with?
IV heroin use | Also can be seen with morphine, methadone, meperidine, and propoxyphene
34
Narcotic induced non-cardiogenic pulmonary edema- mechanism
Idiosyncratic reaction Often seen when Moderate and high doses are used Mechanism is unknown
35
Narcotic induced non-cardiogenic pulmonary edema- sx
May be comatose with depressed respirations, dyspnea and tachypnea Varies from cough to severe cyanosis and hypoxia Decreased pulmonary function tests Appear within minutes of IV administration up to 2 hours
36
Narcotic induced non-cardiogenic pulmonary edema- treatment
``` Clinical improvement within 24-48 hours Pulmonary function abnormality may last up to 12 weeks Treatment Naloxone, oxygen, ventilatory support Mortality less than 1% ```
37
What is the presentation of pulmonary edema?
``` Persistent cough Tachypnea Dyspnea Tachycardia Rales on auscultation Hypoxemia Decreased lung compliance ```
38
What is pulmonary edema reported with?
``` Hydrochlorothiazide Contrast media IV bleomycin, cyclophosphamide and vinblastine (oncology agents) Terbutaline (used as tocolytic) Salicylate overdose ```
39
What is the management for pulmonary edema?
DC medication, supportive care
40
What is pulmonary infiltrates with eosinophilia most frequently associated with?
Nitrofurantoin | Para-aminosalicylic acid (not a drug that you will rx to pts, anti-infective topical)
41
Pulmonary esoinophilia- presentation
Fever, nonproductive cough, dyspnea, cyanosis, bilateral pulmonary infiltrates and eosinophilia in blood
42
Pulmonary eosinophilia- nitrofurantoin
Occurs within 1 month of therapy | Complete recovery within 15 days of DC of medication
43
What is excessive amount of connect tissue in the the intersitial spaces of the lung? Hint- normal airspaces and blood vessels are replaced by fibrotic tissue; lungs become small and stiff and is secondary to chronic inflammatory dz?
Chronic pulmonary fibrosis
44
What can chronic pulmonary fibrosis lead to?
Restrictive airway disease | Can be fatal if process is not stopped
45
Pulmonary fibrosis- causes
Idiopathic pulmonary fibrosis is rare Drug induced pulmonary fibrosis ~ 50 causative agents Prevalence increases with increasing cumulative dose
46
What are the chemotherapeutic agents that cause pulmonary fibrosis?
``` Bleomycin Busulfan Carmustine Methotrexate Amiodarone- not chemo but causes pulmonary fibrosis ```
47
Pulmonary fibrosis-acute phase
``` Non-productive cough Acute dyspnea Tachypnea Lung crackles PFTs- Initially normally, reduced carbon dioxide diffusing capacity Arterial blood gases- Hypoxemia ```
48
Pulmonary fibrosis- chronic phase
``` Slow progression Dyspnea on exertion Fatigue Non-productive cough Lung crackles Clubbing ``` PFTs Restrictive disease, decreased vital capacity Reduced carbon monoxide diffusing capacity
49
Pulmonary fibrosis- time of onset
Acute sx have been seen after 1st dose of bleomycin | Patients have died up to 15 years after receiving therapy.
50
Pulmonary fibrosis- diagnosis
Known exposure to causative drug | No known symptoms, physical findings, laboratory tests or histopathologic findings specific to pulmonary fibrosis
51
Pulmonary fibrosis- management
Discontinuation of medication | +/- prednisone
52
Amiodarone pulmonary toxicity- risk factors
Men Increases with age Pre-existing lung disease Dose/duration- Usually >400 mg/day; seen with 200 mg/day for 6-12 months Occurs 4 weeks to 6 years after initiating therapy
53
Amiodarone pulmonary toxicity- clinical course
Variable- some patients don’t do that bad and some do really bad Progressive dyspnea, malaise, nonproductive cough Rapidly progressive acute respiratory distress syndrome
54
Amiodarone pulmonary toxicity- proposed mechanism
Accumulation of amiodarone and metabolite in lung tissue Interfere with normal processing of phospholipids Breakdown of phospholipid-laden macrophages results in pulmonary inflammation and fibrosis
55
Amiodarone pulmonary toxicity- monitoring
Monitor PFTs and CXR at baseline CXR every year PFTs if symptomatic
56
Amiodarone pulmonary toxicity- management
Majority of patients improve with DC of medication Clinical improvement 1-2 months PFTs and CXR may take up to 18 months +/- corticosteroids
57
What are the medications that cause pulmonary HTN?
``` Anorexic agents- used for weightloss Fenfluramine and dexfenfluarmine (not on the market) Part of “fen-phen” Phentermine 20% of diagnosed cases Onset between 23 days and 27 years ```
58
Pulmonary HTN- symptoms
Generally non-specific Exertional dyspnea: most common Chest pain Syncope
59
Pulmonary HTN- mechanism
unknown
60
Pulmonary HTN- Management
DC medication Improvement within 1-3 months 1997: FDA requested withdrawal of fenfluramine and dexfenfluamine (valvular damage) Phentermine Case reports of pulmonary hypertension Association not supported
61
Oxygen toxicity- presentation
Cough, chest pain, dyspnea Masked in ventilator dependent patients Lungs become progressively stiffer Ability to oxygenate is compromised
62
Oxygen toxicity- normal cellular respiration
Oxidants are counterbalanced by antioxidant defense system (prevents tissue destruction)
63
Oxygen toxicity- excess oxygen (hyperoxia)
Produces highly reactive, partially reduced oxygen metabolites Superoxide anion, hydrogen peroxide, hydroxyl radical, singlet oxygen, hypochlorous acid Overwhelm antioxidant system
64
Oxygen toxicity- lung damage determinants
Fraction of inspired oxygen--50-100% | Duration of exposure- Inversely proportional to fraction of inspired oxygen
65
Oxygen toxicity- lung damage
Acute phase: edema with alveolar hemorrhage | Subacute or chronic phase: collagen and elastin deposition in alveolar walls
66
What does the lung damage in oxygen toxicity lead to?
Thickening of gas exchange area and fibrosis
67
Oxygen toxicity-course
+/- improvement in lung function | May see improvement months to years following exposure